Skip to main content

Table 5 Stability of CTX-HSA-NPs

From: Cabazitaxel-loaded human serum albumin nanoparticles combined with TGFβ-1 siRNA lipid nanoparticles for the treatment of paclitaxel-resistant non-small cell lung cancer

Time

Particle size (nm)

PDI

5% particle < (nm)

90% particle < (nm)

99% particle < (nm)

0 h

108.8 ± 0.9

0.072 ± 0.009

68.4 ± 1.8

150.5 ± 3.5

198.0 ± 7.6

2 h

111.2 ± 4.8

0.085 ± 0.012

67.2 ± 4.1

157.7 ± 7.1

212.3 ± 12.0

4 h

102.6 ± 2.7

0.038 ± 0.054

79.0 ± 16.4

126.2 ± 24.8

152.6 ± 53.4

8 h

107.7 ± 2.4

0.080 ± 0.028

66.4 ± 7.0

150.9 ± 5.3

201.4 ± 16.8

24 h

111.3 ± 2.4

0.055 ± 0.032

75.3 ± 8.7

147.3 ± 11.0

187.2 ± 26.3

48 h

111.3 ± 3.1

0.120 ± 0.054

61.5 ± 7.0

167.4 ± 18.9

238.3 ± 45.6

8 days

112.6 ± 4.6

0.125 ± 0.036

60.7 ± 4.4

171.3 ± 14.9

245.9 ± 33.5

15 days

118.0 ± 8.6

0.161 ± 0.036

58.5 ± 9.2

188.4 ± 6.8

282.3 ± 13.1

24 days

121.7 ± 0.9

0.156 ± 0.041

60.9 ± 5.8

193.5 ± 10.6

288.7 ± 30.5

30 days

221.1 ± 63.0

0.676 ± 0.197

51.4 ± 20.2

525.8 ± 138.8

1120.8 ± 307.8